Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-01-11

FDA Approved: ADVIL PM — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental labeling application for Advil PM, a combination product of diphenhydramine HCl and ibuprofen, by Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL PM (DIPHENHYDRAMINE HCL; IBUPROFEN)

Snippet

SUPPL AP for ADVIL PM (DIPHENHYDRAMINE HCL, IBUPROFEN)